LSD-Pip: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 30: Line 30:


{{stub}}
{{stub}}
<gallery>
File:LSD-Pip.svg|LSD-Pip
</gallery>

Latest revision as of 00:23, 17 March 2025

LSD-Pip is a compound from the ergoline family, related to LSD (Lysergic acid diethylamide). It was first synthesized by Alexander Shulgin and reported in his book TiHKAL (Tryptamines I Have Known And Loved).

Chemistry[edit]

LSD-Pip, or Lysergic acid 2,4-dimethylazetidide, is a synthetic alkaloid, belonging to the lysergamide class. It is structurally similar to LSD, with the diethylamide group replaced by a 2,4-dimethylazetidide group.

Pharmacology[edit]

The pharmacology of LSD-Pip is not well studied. However, it is known to act as a serotonin receptor agonist, like other compounds in the ergoline family. The specific effects and potency of LSD-Pip in humans are not known.

Effects[edit]

The effects of LSD-Pip are largely unknown, as it has not been widely studied or used. However, it is likely to produce effects similar to other lysergamides, which can include hallucinations, altered thought processes, and changes in perception of time and space.

Legal Status[edit]

The legal status of LSD-Pip varies by country. In many places, it is likely to be considered a controlled substance due to its structural similarity to LSD.

See Also[edit]

References[edit]

<references />

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia